TFR Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$358K Sell
3,620
-240
-6% -$25.1K 0.09% 124
2026
Q2
$350K Sell
3,860
-820
-18% -$74.8K 0.1% 128
2026
Q1
$480K Buy
4,680
+671
+17% +$75.8K 0.15% 111
2025
Q4
$502K Buy
4,009
+41
+1% +$5.22K 0.17% 102
2025
Q3
$531K Sell
3,968
-31
-0.8% -$4.07K 0.18% 100
2025
Q2
$544K Buy
3,999
+1,031
+35% +$136K 0.2% 98
2025
Q1
$394K Buy
2,968
+1,048
+55% +$133K 0.16% 103
2024
Q4
$217K Buy
+1,920
New +$222K 0.11% 105

Other funds holding ABT

TFR Capital's ABT Position: Q3 2026 in Review

TFR Capital reduced its Abbott (ABT) stake by 6.2% in Q3 2026, selling an estimated $25.1K and leaving 3,620 shares worth $358K. The position accounts for 0.09% of the portfolio, ranked #124.

TFR Capital first reported a position in ABT in Q4 2024 and has held it in 8 quarters since. The position peaked at $544K in Q2 2025. 2,839 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • TFR Capital held 3,620 shares of Abbott worth $358K as of Q3 2026.
  • TFR Capital sold 240 Abbott shares in Q3 2026, an estimated $25.1K.
  • Abbott made up 0.09% of TFR Capital's portfolio in Q3 2026, its #124 holding.
  • TFR Capital first reported a position in Abbott in Q4 2024 and has held it in 8 quarters since.
  • TFR Capital's Abbott position peaked at $544K in Q2 2025.
  • 2,839 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on TFR Capital's 13F filing for Q3 2026, filed 9 Nov 2026.